General And Administrative Expense of COSCIENS Biopharma Inc. from 31 Dec 2015 to 31 Mar 2024

Taxonomy & unit
ifrs-full: USD
Summary
COSCIENS Biopharma Inc. quarterly and annual General And Administrative Expense in USD history and change rate from 31 Dec 2015 to 31 Mar 2024.
  • COSCIENS Biopharma Inc. General And Administrative Expense for the quarter ending 31 Mar 2024 was $3,514,000, a 52% increase year-over-year.
  • COSCIENS Biopharma Inc. General And Administrative Expense for the twelve months ending 31 Mar 2024 was $6,705,000, a 104% increase year-over-year.
  • COSCIENS Biopharma Inc. annual General And Administrative Expense for 2023 was $5,497,000, a 93% increase from 2022.
  • COSCIENS Biopharma Inc. annual General And Administrative Expense for 2022 was $2,842,000, a 61% decline from 2021.
  • COSCIENS Biopharma Inc. annual General And Administrative Expense for 2021 was $7,267,000, a 23% increase from 2020.
Source SEC data
View on sec.gov
General And Administrative Expense, Trailing 12 Months (USD)
General And Administrative Expense, Quarterly (USD)
General And Administrative Expense, YoY Quarterly Change (%)
General And Administrative Expense, Annual (USD)
General And Administrative Expense, YoY Annual Change (%)

COSCIENS Biopharma Inc. Quarterly General And Administrative Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $6,705,000 $3,514,000 +$1,208,000 +52% 01 Jan 2024 31 Mar 2024 6-K 16 May 2024 2024 Q1
Q4 2023 $5,497,000 $510,000 +$3,886,000 01 Oct 2023 31 Dec 2023 20-F 09 Apr 2025 2024 FY
Q3 2023 $1,611,000 $1,471,000 -$803,000 -35% 01 Jul 2023 30 Sep 2023 6-K 12 Nov 2024 2024 Q3
Q2 2023 $2,414,000 $1,210,000 -$873,000 -42% 01 Apr 2023 30 Jun 2023 6-K 13 Aug 2024 2024 Q2
Q1 2023 $3,287,000 $2,306,000 +$445,000 +24% 01 Jan 2023 31 Mar 2023 6-K 16 May 2024 2024 Q1
Q4 2022 $2,842,000 $3,376,000 -$6,506,000 -208% 01 Oct 2022 31 Dec 2022 20-F 09 Apr 2025 2024 FY
Q3 2022 $9,348,000 $2,274,000 +$1,046,000 +85% 01 Jul 2022 30 Sep 2022 6-K 09 Nov 2023 2023 Q3
Q2 2022 $8,302,000 $2,083,000 +$438,000 +27% 01 Apr 2022 30 Jun 2022 6-K 09 Aug 2023 2023 Q2
Q1 2022 $7,864,000 $1,861,000 +$597,000 +47% 01 Jan 2022 31 Mar 2022 6-K 09 May 2023 2023 Q1
Q4 2021 $7,267,000 $3,130,000 +$682,000 +28% 01 Oct 2021 31 Dec 2021 20-F/A 17 Jul 2024 2023 FY
Q3 2021 $6,585,000 $1,228,000 +$48,000 +4.1% 01 Jul 2021 30 Sep 2021 6-K 03 Nov 2022 2022 Q3
Q2 2021 $6,537,000 $1,645,000 +$504,000 +44% 01 Apr 2021 30 Jun 2021 6-K/A 04 Aug 2022 2022 Q2
Q1 2021 $6,033,000 $1,264,000 +$140,000 +12% 01 Jan 2021 31 Mar 2021 6-K 11 May 2022 2022 Q1
Q4 2020 $5,893,000 $2,448,000 +$757,000 +45% 01 Oct 2020 31 Dec 2020 20-F/A 15 Feb 2024 2022 FY
Q3 2020 $5,136,000 $1,180,000 -$184,000 -13% 01 Jul 2020 30 Sep 2020 6-K 04 Nov 2021 2021 Q3
Q2 2020 $5,320,000 $1,141,000 -$782,000 -41% 01 Apr 2020 30 Jun 2020 6-K 05 Aug 2021 2021 Q2
Q1 2020 $6,102,000 $1,124,000 -$513,000 -31% 01 Jan 2020 31 Mar 2020 6-K 05 May 2021 2021 Q1
Q4 2019 $6,615,000 $1,691,000 01 Oct 2019 31 Dec 2019 20-F 29 Mar 2022 2021 FY
Q3 2019 $1,364,000 -$1,075,000 -44% 01 Jul 2019 30 Sep 2019 6-K 05 Nov 2020 2020 Q3
Q2 2019 $1,923,000 -$81,000 -4% 01 Apr 2019 30 Jun 2019 6-K 06 Aug 2020 2020 Q2
Q1 2019 $1,637,000 01 Jan 2019 31 Mar 2019 6-K/A 11 May 2020 2020 Q1
Q3 2018 $2,439,000 01 Jul 2018 30 Sep 2018 6-K 07 Nov 2019 2019 Q3
Q2 2018 $2,004,000 01 Apr 2018 30 Jun 2018 6-K 13 Aug 2019 2019 Q2

COSCIENS Biopharma Inc. Annual General And Administrative Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $5,497,000 +$2,655,000 +93% 01 Jan 2023 31 Dec 2023 20-F 09 Apr 2025 2024 FY
2022 $2,842,000 -$4,425,000 -61% 01 Jan 2022 31 Dec 2022 20-F 09 Apr 2025 2024 FY
2021 $7,267,000 +$1,374,000 +23% 01 Jan 2021 31 Dec 2021 20-F/A 17 Jul 2024 2023 FY
2020 $5,893,000 -$722,000 -11% 01 Jan 2020 31 Dec 2020 20-F/A 15 Feb 2024 2022 FY
2019 $6,615,000 -$2,279,000 -26% 01 Jan 2019 31 Dec 2019 20-F 29 Mar 2022 2021 FY
2018 $8,894,000 +$696,000 +8.5% 01 Jan 2018 31 Dec 2018 20-F 31 Mar 2020 2019 FY
2017 $8,198,000 +$1,051,000 +15% 01 Jan 2017 31 Dec 2017 20-F 31 Mar 2020 2019 FY
2016 $7,147,000 -$4,161,000 -37% 01 Jan 2016 31 Dec 2016 20-F 01 Apr 2019 2018 FY
2015 $11,308,000 01 Jan 2015 31 Dec 2015 20-F 28 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.